NSW Health is warning the public of multiple high-dose MDMA (ecstasy) tablets in circulation in NSW, found to contain a higher dose than is usually ...
The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.
The independent panel casted doubt on MDMA being a safe and effective treatment. A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of ...
Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results